Basic Information
| ID | DRAMP21307 |
|---|
| Sequence | FVRWWSKWLRRIL |
|---|
| Length | 13 |
|---|
| Name | TL-2 (Derived from Temporin-2Tl (TL)) |
|---|
| Source | Synthetic construct |
|---|
| Activity | Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram- |
|---|
| Pathogen | [Ref.26311041] Gram-positive bacteria : Bacillus subtilis (KCTC 3068)(MIC=4 μM), Staphylococcus epidermidis (KCTC 1917)(MIC=8 μM), Staphylococcus aureus (KCTC 1621)(MIC=2 μM);##Gram-negative bacteria : Escherichia coli (KCTC 1682)(MIC=8 μM), Pseudomonas aeruginosa (KCTC 1637)(MIC=8 μM), Salmonella typhimurium (KCTC 1926)(MIC=4 μM) |
|---|
| Hemolytic Activity | [Ref.26311041] HC50=8.5 μM against human red blood cells |
|---|
| Cytotoxicity | [Ref.26311041] The cell viability of RAW264.7 macrophages cells induced by TL-2 is 111.8%, 112.5% and 81.0% at peptide concentrations of 2.5, 5 and 10 μM. |
|---|
| N-terminal Modification | Free |
|---|
| C-terminal Modification | Amidation |
|---|
| Linear/Cyclic/Branched | Linear |
|---|
| Uniprot |
|
|---|
| PDB |
|
|---|
| 3D View | |
|---|
| PDB Download | Download PDB Predicted by Alphafold2 |
|---|
| PubMed ID | 26311041 |
|---|
